Literature DB >> 25119722

The evaluation and treatment of endocrine forms of hypertension.

Alejandro Velasco1, Wanpen Vongpatanasin.   

Abstract

Endocrine hypertension is an important secondary form of hypertension, identified in between 5% and 10% of general hypertensive population. Primary aldosteronism is the most common cause of endocrine hypertension, accounting for 1%-10% in uncomplicated hypertension and 7%-20% in resistant hypertension. Other less common causes of endocrine hypertension include Cushing syndrome, pheochromocytoma, thyroid disorders, and hyperparathyroidism. Diagnosis requires a high index of suspicion and the use of appropriate screening tests based on clinical presentation. Failure to make proper diagnosis may lead to catastrophic complications or irreversible hypertensive target organ damage. Accordingly, patients who are suspected to have endocrine hypertension should be referred to endocrinologists or hypertension specialists who are familiar with management of the specific endocrine disorders.

Entities:  

Mesh:

Year:  2014        PMID: 25119722     DOI: 10.1007/s11886-014-0528-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  74 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.

Authors:  D H Streeten; G H Anderson; T Howland; R Chiang; H Smulyan
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

3.  Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China.

Authors:  Xiaojing Sang; Yiran Jiang; Weiqing Wang; Li Yan; Jiasheng Zhao; Yongde Peng; Wei Gu; Gang Chen; Wei Liu; Guang Ning
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

4.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

5.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

6.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

Review 7.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

8.  Systemic hemodynamic pattern in primary hyperparathyroidism and its changes after parathyroidectomy.

Authors:  E Valvo; V Bedogna; L Gammaro; P Casagrande; V Ortalda; G Maschio
Journal:  Miner Electrolyte Metab       Date:  1991

9.  Primary aldosteronism in diabetic subjects with resistant hypertension.

Authors:  Guillermo E Umpierrez; Paul Cantey; Dawn Smiley; Andres Palacio; Diana Temponi; Karen Luster; Arlene Chapman
Journal:  Diabetes Care       Date:  2007-04-11       Impact factor: 19.112

10.  Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.

Authors:  Amy McCurley; Paulo W Pires; Shawn B Bender; Mark Aronovitz; Michelle J Zhao; Daniel Metzger; Pierre Chambon; Michael A Hill; Anne M Dorrance; Michael E Mendelsohn; Iris Z Jaffe
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

View more
  3 in total

Review 1.  Ophthalmic clues to the endocrine disorders.

Authors:  Z Liu; Y Chen; Z Lin; X Shi
Journal:  J Endocrinol Invest       Date:  2016-08-27       Impact factor: 4.256

2.  Endocrine hypertension: An overview on the current etiopathogenesis and management options.

Authors:  Reena M Thomas; Ewa Ruel; Prapimporn Ch Shantavasinkul; Leonor Corsino
Journal:  World J Hypertens       Date:  2015

3.  Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.

Authors:  Asife Sahinarslan; Emine Gazi; Meryem Aktoz; Cigdem Ozkan; Gülay Ulusal Okyay; Ozgul Ucar Elalmis; Erdal Belen; Reviewers Atila Bitigen; Ulver Derici; Neslihan Bascil Tutuncu; Aylin Yildirir
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.